Browse

Development of a surrogate marker for P-glycoprotein expression in drug-resistant epilepsy using the (R)-[11C]-Verapamil PET/MR with cyclosporine
난치성 뇌전증에서 사이클로스포린과 (R)-[11C]-Verapamil PET/MR을 이용한 P-glycoprotein 발현의 대리표지자 개발

Cited 0 time in Web of Science Cited 0 time in Scopus
Authors
신정원
Advisor
이상건
Major
의과대학 협동과정임상약리학전공
Issue Date
2016-02
Publisher
서울대학교 대학원
Keywords
P-glycoproteinDrug-resistant epilepsySurrogate markerPET/MR(R)-[11C]-verapamil
Description
학위논문 (박사)-- 서울대학교 대학원 : 의과대학협동과정 임상약리학전공, 2016. 2. 이상건.
Abstract
Background and Purpose: The development of resistance to antiepileptic drugs is explained well by the transporter hypothesis, which suggests that drug resistance is caused by inadequate penetration of drugs into the brain barrier as a result of increased levels of efflux transporter such as p-glycoprotein. To evaluate the brain expression of p-glycoprotein (Pgp) in patients with drug-resistant epilepsy (DRE), including neocortical epilepsy, we developed a non-invasive quantitative analysis including asymmetry indices (AIs) based on (R)-[11C]-verapamil PET/MRI with cyclosporine (CS)
a Pgp inhibitor.
Materials and Methods: Nine patients with DRE, five patients with drug-sensitive epilepsy (DSE), and eight healthy subjects underwent dynamic (R)-[11C]-verapamil PET/MRI with an intravenous infusion of CS. AIs [(right region – left region)/(right region + left region) ×200%] of the standard uptake values in each of the paired lobes were calculated.
Results: All DRE patients, except for patients with parietal lobe epilepsy, had significantly different asymmetry from the healthy subjects, whereas all DSE patients had asymmetry similar to healthy subjects. In the temporal lobe, the AIs of patients with left temporal lobe DRE were more positive than those of healthy subjects (healthy subjects: 4.0413 ± 1.7452
patients: 7.2184 ± 1.8237
p = 0.048), and those of patients with right temporal DRE were more negative (patients: -1.6496 ± 3.4136
p = 0.044). In addition, specific regions which had significant asymmetry were different between lateral and medial temporal lobe epilepsy groups. In the frontal lobe, the AI of patient with right frontal lobe DRE was more negative than healthy subjects.
Conclusions: We confirmed that Statistical Parametric Mapping analysis using AIs of (R)-[11C]-verapamil PET/MRI with CS could be used as a surrogate marker for DRE, and this approach might be helpful for localizing or lateralizing the epileptic zone. ClinicalTrials.gov number: NCT02144792
Language
English
URI
https://hdl.handle.net/10371/121791
Files in This Item:
Appears in Collections:
College of Medicine/School of Medicine (의과대학/대학원)Program in Clinical Pharmacology (협동과정-임상약리학전공)Theses (Ph.D. / Sc.D._협동과정-임상약리학전공)
  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse